Quarterly test volume of over 4,000 tests represented sequential increase of 45 percent NEW YORK, Jan. 13, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc....
Read More Details
Finally We wish PressBee provided you with enough information of ( Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume )
Also on site :
- 'General Hospital' Fans Brace for 'Slap in the Face' amid Star's Return
- Billionaire Telegram founder leaves his $14 billion fortune to the 100+ children he’s fathered—which means $132 million for each lucky Gen Alpha kid
- Sandra Oh Makes a Bold Statement About Whether She’ll Return to 'Grey’s Anatomy'